Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses.

The research article explores two naturally occurring models of severe combined immunodeficiency (SCID) in domestic animals—canine X-linked SCID and SCID in horses. The study hopes that these models can be useful in understanding the defects in human SCID, propose novel therapeutic interventions, and strategies to treat secondary infections linked with SCID.

Canine X-Linked Severe Combined Immunodeficiency

• This model showcases an X-linked recessive mode of inheritance. This mirrors the most common type of SCID in humans in the USA. Interestingly, dogs affected by this disorder have normal percentages of B cells and low to normal percentages of phenotypically mature T cells. However, these T cells are nonfunctional, thereby impairing the dog’s immune response.
• The utility of this model lies in the fact that it is genotypically similar to the human form of the disease. Thus, it can be leveraged to study the underlying genetics of X-linked SCID, map out the intricacies of the resultant immune defects, and experiment with innovative approaches to immunotherapy or gene therapy.

Severe Combined Immunodeficiency in Horses

• This model of SCID in horses follows an autosomal recessive pattern of inheritance. This type of immunodeficiency is characterized by a significant decrease in both B and T cells, implicating that the disease likely stems from a defect in the lymphoid stem cells.
• This form of SCID provides a suitable model for its corresponding human form as well. The researchers suggest that exploring its pathophysiology could unravel the underlying causes of the human SCID phenotype. This information holds enormous therapeutic potential – from customizing novel gene therapies to finding effective treatments for opportunistic infections commonly associated with SCID.

Utility of Animal Models

• Both these animal models occur naturally in an outbred population, much like how SCID appears in humans. This similarity increases the relevance of the models and enhances the translational prospects of research findings.
• Studying these models further can provide pivotal insights into the specific genetic and immunodeficiency features of SCID. It can also facilitate the evaluation of novel therapies and inform the management of infection complications that often accompany SCID.